VOR Logo

Vor Biopharma Inc. (VOR) 

NASDAQ
Market Cap
$55.6M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
396 of 775
Rank in Industry
205 of 432

Largest Insider Buys in Sector

VOR Stock Price History Chart

VOR Stock Performance

About Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a …

Insider Activity of Vor Biopharma Inc.

Over the last 12 months, insiders at Vor Biopharma Inc. have bought $0 and sold $20,357 worth of Vor Biopharma Inc. stock.

On average, over the past 5 years, insiders at Vor Biopharma Inc. have bought $73.63M and sold $5.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,979,566 shares for transaction amount of $53.63M was made by RA CAPITAL MANAGEMENT, L.P. () on 2021‑02‑09.

List of Insider Buy and Sell Transactions, Vor Biopharma Inc.

2024-06-03SaleCHIEF MEDICAL OFFICER
14,645
0.0209%
$1.39$20,357-35.87%
2021-11-16Sale
330,706
0.7914%
$15.30$5.06M-69.06%
2021-11-16Sale10 percent owner
330,706
0.7914%
$15.30$5.06M-69.06%
2021-02-09Purchase
2.98M
5.6047%
$18.00$53.63M-63.24%
2021-02-09Purchase
555,555
1.045%
$18.00$10M-63.24%
2021-02-09Purchase10 percent owner
555,555
1.045%
$18.00$10M-63.24%

Insider Historical Profitability

<0.0001%
RA CAPITAL MANAGEMENT, L.P.
8297265
12.0822%
$0.8110<0.0001%
PARMAR KUSH
1766634
2.5725%
$0.8111<0.0001%
5AM Ventures VI, L.P.10 percent owner
1766634
2.5725%
$0.8111<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
RA Capital Management, L.P.$53.91M33.3322.75M0%+$00.05
Fidelity Investments$18.03M11.157.61M-0.14%-$24,906.33<0.01
Paradigm BioCapital Advisors LP$15.3M9.466.46M0%+$00.56
5Am Venture Management Llc$15.08M9.326.36M0%+$01.01
Laurion Capital Management LP$7.54M4.663.18M0%+$00.05
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.